<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.52575/2687-0940-2022-45-2-141-151</article-id><article-id pub-id-type="publisher-id">113</article-id><article-categories><subj-group subj-group-type="heading"><subject>CARDIOLOGY</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Influence of electrical activity of the myocardium on the formation of atrial fibrillation in patients in the postinfarction period&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Influence of electrical activity of the myocardium on the formation of atrial fibrillation in patients in the postinfarction period&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Shevchenko</surname><given-names>Aleksander S.</given-names></name><name xml:lang="en"><surname>Shevchenko</surname><given-names>Aleksander S.</given-names></name></name-alternatives><email>shevchenko-as@inbox.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Schukina</surname><given-names>Elena V.</given-names></name><name xml:lang="en"><surname>Schukina</surname><given-names>Elena V.</given-names></name></name-alternatives><email>Shuliksany@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Aleshechkin</surname><given-names>Pavel A.</given-names></name><name xml:lang="en"><surname>Aleshechkin</surname><given-names>Pavel A.</given-names></name></name-alternatives><email>alyoshechkin.pavel22@gmail.com</email></contrib></contrib-group><pub-date pub-type="epub"><year>2022</year></pub-date><volume>45</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2022/2/141-151.pdf" /><abstract xml:lang="ru"><p>Atrial fibrillation is one of the most common arrhythmias in the world, which can occur as a complication in up to 27&amp;nbsp;% of cases in patients with acute myocardial infarction. The article presents the results of a study in which 114 patients with acute myocardial infarction took part. Follow-up was carried out for 1 year after myocardial infarction. All patients were divided into 4 groups according to gender and the presence of atrial fibrillation. According to the data of 24-hour ECG monitoring, the indicators of rhythm and conduction disturbances were assessed. When comparing groups of men and women with atrial fibrillation and sinus rhythm, it was found that statistically significant differences in same-sex groups with atrial fibrillation and sinus rhythm were: the duration of the PQ interval in the daytime and at night, the number of single, paired and group supraventricular extrasystoles. Thus, pathological supraventricular ectopic activity, in the form of extrasystolic arrhythmia, had a direct relationship with the development of atrial fibrillation, and impaired AV conduction (in the form of a prolongation of the PQ interval on the ECG) had an inverse relationship.</p></abstract><trans-abstract xml:lang="en"><p>Atrial fibrillation is one of the most common arrhythmias in the world, which can occur as a complication in up to 27&amp;nbsp;% of cases in patients with acute myocardial infarction. The article presents the results of a study in which 114 patients with acute myocardial infarction took part. Follow-up was carried out for 1 year after myocardial infarction. All patients were divided into 4 groups according to gender and the presence of atrial fibrillation. According to the data of 24-hour ECG monitoring, the indicators of rhythm and conduction disturbances were assessed. When comparing groups of men and women with atrial fibrillation and sinus rhythm, it was found that statistically significant differences in same-sex groups with atrial fibrillation and sinus rhythm were: the duration of the PQ interval in the daytime and at night, the number of single, paired and group supraventricular extrasystoles. Thus, pathological supraventricular ectopic activity, in the form of extrasystolic arrhythmia, had a direct relationship with the development of atrial fibrillation, and impaired AV conduction (in the form of a prolongation of the PQ interval on the ECG) had an inverse relationship.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>atrial fibrillation</kwd><kwd>myocardial infarction</kwd><kwd>extrasystolic arrhythmia</kwd><kwd>PQ interval</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>myocardial infarction</kwd><kwd>extrasystolic arrhythmia</kwd><kwd>PQ interval</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Baranova E.I. 2018. Novye standarty bezopasnosti antikoagulyantnoy terapii pri fibrillyatsii predserdiy [New safety standards for anticoagulant therapy in the treatment of atrial fibrillation]. Rossiyskiy kardiologicheskiy zhurnal. 10: 136&amp;ndash;144. https://doi.org/10.15829/1560-4071-2018-10-136-144</mixed-citation></ref><ref id="B2"><mixed-citation>Boldueva S.A., Solov&amp;#39;eva M.V., Oblavatskiy D.V., Feoktistova V.S. 2020. Infarkt miokarda u bol&amp;#39;nykh s fibrillyatsiey predserdiy [Myocardial Infarction in the Group of Patients With Atrial Fibrillation]. Kardiologiya. 60 (1): 53&amp;ndash;61. https://doi.org/10.18087/cardio.2020.1.n620</mixed-citation></ref><ref id="B3"><mixed-citation>Borodashkina S.Yu, Protasov K.V. 2020. Kliniko-patogeneticheskie osobennosti infarkta miokarda u bol&amp;#39;nykh fibrillyatsiey predserdiy [Clinical and pathogenetic features of myocardial infarction in patients with atrial fibrillation]. Sibirskoe meditsinskoe obozrenie. (5): 31&amp;ndash;39. DOI: 10.20333/2500136-2020-5-31-39</mixed-citation></ref><ref id="B4"><mixed-citation>Bunin Yu.A., Miklishanskaya S.V., Chigineva V.V., Zolozova E.A. 2018. Fibrillyatsiya predserdiy i zheludochkovye aritmii pri infarkte miokarda s pod&amp;quot;emom segmenta ST: vozmozhnosti farmakoterapii i nemedikamentoznogo lecheniya [Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment]. Ratsional&amp;#39;naya Farmakoterapiya v Kardiologii. 14 (4): 605&amp;ndash;611. DOI: 10.20996/1819-6446-2018-14-4-605-611</mixed-citation></ref><ref id="B5"><mixed-citation>Bkhattaray R., Sayganov S.A., Trofimova E.V. 2015. Fibrillyatsiya predserdiy pri infarkte miokarda razlichnoy lokalizatsii [Atrial fibrillation in myocardial infarction of various localization]. RFK 1.</mixed-citation></ref><ref id="B6"><mixed-citation>Grigoryan S.V., Azarapetyan L.G., Adamyan K.G. 2018. Miokardial&amp;#39;nyy fibroz i fibrillyatsiya predserdiy [Myocardial fibrosis and atrial fibrillation]. RKZh. 9.</mixed-citation></ref><ref id="B7"><mixed-citation>Zykov M.V., Barbarash O.L. 2021. Patogeneticheskie i klinicheskie aspekty fibrillyatsii predserdiy pri infarkte miokarda [Pathogenesis and clinical significance of atrial fibrillation in myocardial infarction]. Rossiyskiy kardiologicheskiy zhurnal. 26 (2): 4307. doi: 10.15829/1560-4071-2021-4307</mixed-citation></ref><ref id="B8"><mixed-citation>Kenzhaev M.L., Rizaeva M.Zh. 2020. Vyyavlenie prediktorov fibrillyatsii predserdiy u bol&amp;#39;nykh ishemicheskoy bolezn&amp;#39;yu serdtsa [Identification of predictors of atrial fibrillation in patients with coronary heart disease]. Novyy den&amp;#39; v meditsine. 2 (30): 403&amp;ndash;406.</mixed-citation></ref><ref id="B9"><mixed-citation>Muinova K.K., Tashkenbaeva E.N., Madzhidova G.T., Alieva N.K., Istamova S.S. 2019. Rol&amp;#39; faktorov riska v razvitii infarkta miokarda u muzhchin molodogo vozrasta v zavisimosti ot semeynogo anamneza [The role of risk factors in the development of myocardial infarction in young men depending on family history]. Dostizheniya nauki i obrazovaniya. 11 (52).</mixed-citation></ref><ref id="B10"><mixed-citation>Red&amp;#39;ka A.V., Chernykh T.M. 2018. Prognosticheskie faktory fibrillyatsii predserdiy u bol&amp;#39;nykh IBS i metabolicheskim sindromom [Prognostic factors of atrial fibrillation in patients with ischemic heart disease and metabolic syndrome]. Sovremennaya nauka: aktual&amp;#39;nye problemy teorii i praktiki. Seriya: Estestvennye i tekhnicheskie nauki. 10: 93&amp;ndash;96.</mixed-citation></ref><ref id="B11"><mixed-citation>Solov&amp;#39;eva M.V., Boldueva S.A. 2021. Prognosticheskoe znachenie fibrillyatsii predserdiy u bol&amp;#39;nykh, perenesshikh infarkt miokarda. Rezul&amp;#39;taty mnogoletnego nablyudeniya [Prognostic value of atrial fibrillation in patients with myocardial infarction. Long-term follow-up results]. Rossiyskiy kardiologicheskiy zhurnal. 26 (2): 4285. doi: 10.15829/1560-4071-2021-4285</mixed-citation></ref><ref id="B12"><mixed-citation>Filippova M.O., Polunina O.S., Voronina L.P., Shagina L.V. 2017. Prognozirovanie razvitiya paroksizma fibrillyatsii predserdiy u patsientov s postinfarktnym kardiosklerozom [Prediction of paroxysm of atrial fibrillation in patients with postinfarction cardiosclerosis]. Kubanskiy nauchnyy meditsinskiy vestnik. 24 (3): 114&amp;ndash;119. DOI: 10.25207/1608-6228-2017-24-3-114-119</mixed-citation></ref><ref id="B13"><mixed-citation>Fomina I.G., D&amp;#39;yakova T.A. 2006. Gipertrofiya levogo zheludochka pri arterial&amp;#39;noy gipertenzii i risk razvitiya aritmiy [Left ventricular hypertrophy in arterial hypertension and arrhythmia risk]. KVTiP. 5 (8): 83&amp;ndash;89.</mixed-citation></ref><ref id="B14"><mixed-citation>Crenshaw B.S., Ward S.R., Granger C.B., Stebbins A.L., Topol E.J. &amp;amp; Califf R.M. 1997. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Journal of the American College of Cardiology. 30 (2): 406&amp;ndash;413. https://doi.org/10.1016/s0735-1097(97)00194-0</mixed-citation></ref><ref id="B15"><mixed-citation>Klass M., Haywood L.J. 1970. Atrial fibrillation associated with acute myocardial infarction: A study of 34 cases. American Heart Journal, 79, 752&amp;ndash;760. http://dx.doi.org/10.1016/0002-8703(70)90362-5</mixed-citation></ref><ref id="B16"><mixed-citation>Koren O., Azaizah M., Rozner E., Elias M., &amp;amp; Turgeman Y. 2020. Role of thrombin generation assays in the diagnosis of acute myocarditis and non-ST myocardial infarction. Journal of thrombosis and thrombolysis. 50 (1): 144&amp;ndash;150. https://doi.org/10.1007/s11239-019-01996-6</mixed-citation></ref><ref id="B17"><mixed-citation>Mart&amp;iacute;-Almor J., Jim&amp;eacute;nez-L&amp;oacute;pez J., Casteigt B., Conejos J., Valles E., Farr&amp;eacute; N., Flor M.F. 2021. Obstructive Sleep Apnea Syndrome as a Trigger of Cardiac Arrhythmias. Curr Cardiol Rep. 23 (3): 20. doi: 10.1007/s11886-021-01445-y. PMID: 33611699.</mixed-citation></ref><ref id="B18"><mixed-citation>Schnabel R.B., Yin X., Gona P., Larson M.G., Beiser A.S., McManus D.D., Newton-Cheh C., Lubitz&amp;nbsp;S.A., Magnani J.W., Ellinor P.T., Seshadri S., Wolf P.A., Vasan R.S., Benjamin E.J., Levy&amp;nbsp;D. 2015. 50 year trends in atrial fi brillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study, The Lancet. doi: 10.1016/S0140-6736(14)61774-8.</mixed-citation></ref><ref id="B19"><mixed-citation>Thomas L., Abhayaratna W.P. 2017. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc. Imaging. 10 (1): 65&amp;ndash;77. DOI: 10.1016/j.jcmg.2016.11.003</mixed-citation></ref><ref id="B20"><mixed-citation>Zhao X., Li H., Liu C., Ren Y., Sun C. 2022. NT Pro-BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement. Clinical cardiology. 45 (1): 68&amp;ndash;74.</mixed-citation></ref></ref-list></back></article>